Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes

Enrolling by invitationOBSERVATIONAL
Enrollment

302

Participants

Timeline

Start Date

April 10, 2018

Primary Completion Date

June 30, 2031

Study Completion Date

June 30, 2031

Conditions
Type 2 Diabetes MellitusObesity
Interventions
PROCEDURE

Bariatric surgery involving Roux-en-Y gastric bypass

Subjects previously underwent Bariatric surgery involving Roux-en-Y gastric bypass (RYGB) surgery at one of the 4 participating sites and will be followed prospectively.

PROCEDURE

Bariatric surgery involving Laparoscopic adjustable gastric banding

Subjects previously underwent Bariatric surgery involving laparoscopic adjustable gastric banding (LAGB) surgery at one of the 4 participating sites and will be followed prospectively.

PROCEDURE

Bariatric surgery involving Laparoscopic sleeve gastrectomy

Subjects previously underwent Bariatric surgery involving laparoscopic sleeve gastrectomy (LSG) surgery at one of the 4 participating sites and will be followed prospectively.

Trial Locations (4)

15213

University of Pittsburg Medical Center, Pittsburgh

44195

Cleveland Clinic Digestive Disease Institute, Cleveland

98108

University of Washington, Seattle

02215

Joslin Diabetes Center, Boston

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

The Cleveland Clinic

OTHER

lead

Ali Aminian

OTHER